BG66240B1 - Аминоалкилбензоил - бензофурани или бензотиофени, метод за получаването им и състави, които ги съдържат - Google Patents

Аминоалкилбензоил - бензофурани или бензотиофени, метод за получаването им и състави, които ги съдържат Download PDF

Info

Publication number
BG66240B1
BG66240B1 BG107527A BG10752703A BG66240B1 BG 66240 B1 BG66240 B1 BG 66240B1 BG 107527 A BG107527 A BG 107527A BG 10752703 A BG10752703 A BG 10752703A BG 66240 B1 BG66240 B1 BG 66240B1
Authority
BG
Bulgaria
Prior art keywords
group
benzofuran
general formula
compound
straight
Prior art date
Application number
BG107527A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG107527A (bg
Inventor
Jean-Lois ASSENS
Claude Bernhart
- HAUDRICOURT Frederique CABANEL
Patrick Gautier
Dino Nisato
Original Assignee
Sanofi - Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi - Synthelabo filed Critical Sanofi - Synthelabo
Publication of BG107527A publication Critical patent/BG107527A/bg
Publication of BG66240B1 publication Critical patent/BG66240B1/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
BG107527A 2000-08-23 2003-02-05 Аминоалкилбензоил - бензофурани или бензотиофени, метод за получаването им и състави, които ги съдържат BG66240B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0010834A FR2813306B1 (fr) 2000-08-23 2000-08-23 Aminoalkybenzoyl-benzofurannes ou benzothiophenes, leur procede de preparation et les compositions les contenant
PCT/FR2001/002640 WO2002016339A1 (fr) 2000-08-23 2001-08-21 Aminoalkylbenzoyl-benzofuranes ou benzothiophenes, leur procede de preparation et les compositions les contenant

Publications (2)

Publication Number Publication Date
BG107527A BG107527A (bg) 2003-10-31
BG66240B1 true BG66240B1 (bg) 2012-08-31

Family

ID=8853674

Family Applications (1)

Application Number Title Priority Date Filing Date
BG107527A BG66240B1 (bg) 2000-08-23 2003-02-05 Аминоалкилбензоил - бензофурани или бензотиофени, метод за получаването им и състави, които ги съдържат

Country Status (36)

Country Link
US (1) US6949583B2 (US06949583-20050927-C00142.png)
EP (1) EP1315709B1 (US06949583-20050927-C00142.png)
JP (2) JP5081363B2 (US06949583-20050927-C00142.png)
KR (1) KR100911280B1 (US06949583-20050927-C00142.png)
CN (1) CN1246315C (US06949583-20050927-C00142.png)
AR (1) AR032892A1 (US06949583-20050927-C00142.png)
AT (1) ATE469138T1 (US06949583-20050927-C00142.png)
AU (2) AU8414901A (US06949583-20050927-C00142.png)
BG (1) BG66240B1 (US06949583-20050927-C00142.png)
BR (1) BR0113425B1 (US06949583-20050927-C00142.png)
CA (1) CA2415847C (US06949583-20050927-C00142.png)
CY (1) CY1110738T1 (US06949583-20050927-C00142.png)
CZ (1) CZ304003B6 (US06949583-20050927-C00142.png)
DE (1) DE60142240D1 (US06949583-20050927-C00142.png)
DK (1) DK1315709T3 (US06949583-20050927-C00142.png)
EA (1) EA006237B1 (US06949583-20050927-C00142.png)
ES (1) ES2346291T3 (US06949583-20050927-C00142.png)
FR (1) FR2813306B1 (US06949583-20050927-C00142.png)
HK (1) HK1053113A1 (US06949583-20050927-C00142.png)
HU (1) HU229456B1 (US06949583-20050927-C00142.png)
IL (2) IL153632A0 (US06949583-20050927-C00142.png)
IS (1) IS2821B (US06949583-20050927-C00142.png)
MA (1) MA26943A1 (US06949583-20050927-C00142.png)
ME (2) MEP23008A (US06949583-20050927-C00142.png)
MX (1) MXPA03001463A (US06949583-20050927-C00142.png)
NO (1) NO328138B1 (US06949583-20050927-C00142.png)
NZ (1) NZ523446A (US06949583-20050927-C00142.png)
OA (1) OA12359A (US06949583-20050927-C00142.png)
PL (1) PL219848B1 (US06949583-20050927-C00142.png)
PT (1) PT1315709E (US06949583-20050927-C00142.png)
RS (1) RS51603B (US06949583-20050927-C00142.png)
SI (1) SI1315709T1 (US06949583-20050927-C00142.png)
SK (1) SK288126B6 (US06949583-20050927-C00142.png)
TW (1) TWI290920B (US06949583-20050927-C00142.png)
WO (1) WO2002016339A1 (US06949583-20050927-C00142.png)
ZA (1) ZA200300744B (US06949583-20050927-C00142.png)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7401072B2 (en) * 2003-06-10 2008-07-15 Google Inc. Named URL entry
KR20080015077A (ko) * 2005-05-05 2008-02-18 사노피-아벤티스 유.에스. 엘엘씨 안정한 나노입자 제형
FR2893616B1 (fr) * 2005-11-23 2008-01-04 Sanofi Aventis Sa Nouveaux derives d'indolizine, leur procede de preparation et les compositions therapeutiques les comprenant
CN1946120B (zh) * 2006-10-20 2010-05-12 华为技术有限公司 实现话单关联的方法及系统
EP2308488A1 (en) 2009-10-09 2011-04-13 Sanofi-Aventis Use of celivarone for the preparation of a medicament for use in the prevention of implantable cardioverter defibrillator interventions or death
US20110207811A1 (en) * 2010-02-19 2011-08-25 Sanofi-Aventis Use of celivarone for reducing occurrences of cardiovascular hospitalization
FR2958290B1 (fr) 2010-03-30 2012-10-19 Sanofi Aventis Procede de preparation de derives de sulfonamido-benzofurane
HUP1000330A2 (en) 2010-06-18 2011-12-28 Sanofi Sa Process for the preparation of dronedarone and the novel intermediates
AU2011202542A1 (en) 2010-07-14 2012-02-02 Indian Institute Of Science Benzothiophene carboxamide compounds, composition and applications thereof
FR2963006B1 (fr) 2010-07-21 2013-03-15 Sanofi Aventis Procede de preparation de derives de nitro-benzofurane
FR2967067A1 (fr) 2010-11-10 2012-05-11 Sanofi Aventis Composition pharmaceutique et forme galenique a base de dronedarone et son procede de preparation
HUP1100167A2 (en) 2011-03-29 2012-11-28 Sanofi Sa Process for preparation of dronedarone by mesylation
HUP1100165A2 (en) 2011-03-29 2012-12-28 Sanofi Sa Process for preparation of dronedarone by n-butylation
CN102757444B (zh) * 2011-04-29 2016-02-10 南京信诺泰医药有限公司 具有一氧化氮供体性质的苯并呋喃类化合物
FR2983198B1 (fr) 2011-11-29 2013-11-15 Sanofi Sa Procede de preparation de derives de 5-amino-benzoyl-benzofurane
EP2617718A1 (en) 2012-01-20 2013-07-24 Sanofi Process for preparation of dronedarone by the use of dibutylaminopropanol reagent
US9221778B2 (en) 2012-02-13 2015-12-29 Sanofi Process for preparation of dronedarone by removal of hydroxyl group
US9249119B2 (en) 2012-02-14 2016-02-02 Sanofi Process for the preparation of dronedarone by oxidation of a sulphenyl group
US9382223B2 (en) 2012-02-22 2016-07-05 Sanofi Process for preparation of dronedarone by oxidation of a hydroxyl group
WO2013178337A1 (en) 2012-05-31 2013-12-05 Sanofi Process for preparation of dronedarone by grignard reaction
CN105315245B (zh) * 2014-06-16 2018-10-12 华润赛科药业有限责任公司 苯并呋喃类衍生物、其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3248401A (en) * 1966-04-26 Diethylaminoe hoxybenzoyl benzofurans
GB1345872A (en) * 1970-09-03 1974-02-06 Wyeth John & Brother Ltd Amino-and acylamino-pyridine and hydropyridine derivatives
US4851554A (en) * 1987-04-06 1989-07-25 University Of Tennessee Research Corporation Certain 3-substituted 2-alkyl benzofuran derivatives
US4806663A (en) * 1987-04-06 1989-02-21 The University Of Tennessee Research Corporation Certain 3-substituted 2-alkyl benzofuran derivatives
US4831054A (en) * 1988-04-18 1989-05-16 Taro Pharmaceuticals, Ltd. 2-Alkyl-3-benzoylbenzofurans useful for treating cardiac arrhythmia
AT391316B (de) * 1988-09-15 1990-09-25 Ebewe Arzneimittel Neue thienyloxy-alkylamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FR2665444B1 (fr) * 1990-08-06 1992-11-27 Sanofi Sa Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant.
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
US5482949A (en) * 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
US5364880A (en) * 1993-06-16 1994-11-15 Advanced Therapies, Inc. Compound for treatment of cardiac arrhythmia, synthesis, and methods of use
US6756388B1 (en) * 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
US5482950A (en) * 1993-10-15 1996-01-09 Eli Lilly And Company Methods for lowering serum cholesterol
US5523309A (en) * 1995-03-10 1996-06-04 Eli Lilly And Company Benzofuran pharmaceutical compounds
CA2217373A1 (en) 1996-10-10 1998-04-10 Michael John Martin Benzo¬b|thiophene compounds, intermediates, formulations, and methods

Also Published As

Publication number Publication date
DE60142240D1 (de) 2010-07-08
NO20030800L (no) 2003-04-23
IL153632A (en) 2007-07-24
EA200300062A1 (ru) 2003-08-28
AU8414901A (en) 2002-03-04
HUP0302968A3 (en) 2005-02-28
ATE469138T1 (de) 2010-06-15
HU229456B1 (en) 2013-12-30
RS51603B (sr) 2011-08-31
SK2162003A3 (en) 2003-08-05
NO328138B1 (no) 2009-12-14
ES2346291T3 (es) 2010-10-14
BR0113425B1 (pt) 2014-02-25
KR20030023767A (ko) 2003-03-19
KR100911280B1 (ko) 2009-08-11
CA2415847A1 (fr) 2002-02-28
CA2415847C (fr) 2011-09-27
JP5081363B2 (ja) 2012-11-28
CN1246315C (zh) 2006-03-22
MXPA03001463A (es) 2004-05-04
CN1471521A (zh) 2004-01-28
OA12359A (fr) 2006-05-16
MA26943A1 (fr) 2004-12-20
BR0113425A (pt) 2003-07-15
HK1053113A1 (en) 2003-10-10
US20030225100A1 (en) 2003-12-04
CY1110738T1 (el) 2015-06-10
PL362119A1 (en) 2004-10-18
JP2004506727A (ja) 2004-03-04
SI1315709T1 (sl) 2010-09-30
IS6677A (is) 2003-01-13
WO2002016339A1 (fr) 2002-02-28
DK1315709T3 (da) 2010-09-20
NZ523446A (en) 2004-12-24
BG107527A (bg) 2003-10-31
EP1315709B1 (fr) 2010-05-26
AR032892A1 (es) 2003-12-03
NO20030800D0 (no) 2003-02-20
JP5603849B2 (ja) 2014-10-08
HUP0302968A2 (hu) 2003-12-29
JP2012097100A (ja) 2012-05-24
SK288126B6 (sk) 2013-10-02
FR2813306B1 (fr) 2005-10-21
YU12903A (sh) 2006-05-25
US6949583B2 (en) 2005-09-27
EP1315709A1 (fr) 2003-06-04
FR2813306A1 (fr) 2002-03-01
IS2821B (is) 2013-02-15
EA006237B1 (ru) 2005-10-27
TWI290920B (en) 2007-12-11
AU2001284149B2 (en) 2006-09-21
ME00106B (me) 2010-10-10
CZ2003521A3 (cs) 2003-05-14
PT1315709E (pt) 2010-07-29
IL153632A0 (en) 2003-07-06
PL219848B1 (pl) 2015-07-31
CZ304003B6 (cs) 2013-08-14
ZA200300744B (en) 2004-02-05
MEP23008A (en) 2010-06-10

Similar Documents

Publication Publication Date Title
JP5603849B2 (ja) アミノアルキルベンゾイル−ベンゾフランまたはベンゾチオフェン誘導体を含む医薬組成物
JP2852659B2 (ja) ピペラジン誘導体およびその塩
CZ288527B6 (cs) Derivát benzofuranu, benzothiofenu, indolu nebo indolizinu, způsob jejich přípravy, jejich použití a farmaceutický prostředek, který je obsahuje
JPH05112566A (ja) ピラゾロピリジン化合物およびその製造方法
JP5140226B2 (ja) アミノアルコキシベンゾイル−ベンゾフランまたはベンゾチオフェン誘導体、その製造方法およびそれを含む組成物
EP0597112A1 (en) Novel imidazole derivative, pharmaceutical use thereof, and intermediate therefor
KR900006721B1 (ko) 2,6-피페리딘디온 유도체의 제조방법
JP2834506B2 (ja) 新規チエニルオキシ‐アルキルアミン誘導体、その製法及びこの化合物を含有する医薬
JP4918209B2 (ja) アミノアルケニルベンゾイル−ベンゾフランまたはベンゾチオフェン誘導体、その製造方法およびそれを含む組成物
US4851411A (en) 5-monoaryl as.-triazin-3-ones substituted in 2-position, and their use as medicaments
JP4463900B2 (ja) フェニルアゾール化合物、製造法及び抗高脂血症薬
JPH03223265A (ja) 環状ジアミン誘導体
JPH0372422A (ja) 抗脂血剤
JPH0529031B2 (US06949583-20050927-C00142.png)
JPH06211770A (ja) シアノアミジン誘導体